Deutsche Bank began coverage on shares of Anthem (NYSE:ANTM) in a report issued on Thursday morning, 24/7 WallStreet reports. The firm issued a buy rating on the stock.
ANTM has been the topic of a number of other research reports. Morgan Stanley boosted their target price on Anthem from $359.00 to $371.00 and gave the stock an overweight rating in a research note on Friday, July 12th. Wells Fargo & Co restated a buy rating on shares of Anthem in a research note on Friday, July 26th. ValuEngine downgraded Anthem from a hold rating to a sell rating in a research note on Thursday, August 22nd. Finally, Zacks Investment Research downgraded Anthem from a buy rating to a hold rating and set a $289.00 target price on the stock. in a research note on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and fifteen have assigned a buy rating to the company. Anthem has a consensus rating of Buy and a consensus target price of $325.40.
ANTM stock traded up $6.49 during mid-day trading on Thursday, reaching $254.65. 142,919 shares of the company traded hands, compared to its average volume of 1,422,599. The stock has a market cap of $63.48 billion, a price-to-earnings ratio of 16.05, a P/E/G ratio of 0.93 and a beta of 0.74. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.57. Anthem has a fifty-two week low of $227.16 and a fifty-two week high of $317.99. The firm’s 50 day moving average price is $274.20 and its 200 day moving average price is $280.84.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be paid a $0.80 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.20 annualized dividend and a yield of 1.26%. Anthem’s payout ratio is 20.14%.
In related news, Director Robert L. Dixon, Jr. sold 520 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $294.11, for a total value of $152,937.20. Following the transaction, the director now owns 9,971 shares in the company, valued at $2,932,570.81. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.17% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of ANTM. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in Anthem by 101.2% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 3,821,672 shares of the company’s stock valued at $1,078,514,000 after purchasing an additional 1,921,814 shares during the last quarter. Nuveen Asset Management LLC lifted its stake in Anthem by 5,130.7% in the second quarter. Nuveen Asset Management LLC now owns 1,531,222 shares of the company’s stock valued at $432,125,000 after purchasing an additional 1,501,948 shares during the last quarter. Boston Partners lifted its stake in Anthem by 33.9% in the second quarter. Boston Partners now owns 2,437,084 shares of the company’s stock valued at $688,249,000 after purchasing an additional 617,137 shares during the last quarter. Egerton Capital UK LLP lifted its stake in Anthem by 176.8% in the first quarter. Egerton Capital UK LLP now owns 694,185 shares of the company’s stock valued at $199,217,000 after purchasing an additional 443,428 shares during the last quarter. Finally, Prudential PLC lifted its stake in Anthem by 108.1% in the second quarter. Prudential PLC now owns 821,298 shares of the company’s stock valued at $231,673,000 after purchasing an additional 426,668 shares during the last quarter. Institutional investors and hedge funds own 89.26% of the company’s stock.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Read More: What is insider trading?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.